Abstract
Rheumatology has been a neglected subspecialty in India. A staggering patient load, a severely inadequate number of trained rheumatology specialists, therapeutic nihilism and limited advocacy are some of the critical challenges that confront rheumatology care, and possibly explain the high rates of reliance on complementary and alternative medicines in India. Disease spectrum and treatment patterns are not remarkably different from those in other countries, but biologic agents have limited use and are administered for short periods only. Consequently, outcomes in India do not yet match those reported in developed countries. Furthermore, the high prevalence of infectious diseases continues to be a major contributor to mortality in patients with rheumatic disorders such as systemic lupus erythematosus. Several tropical diseases with rheumatic manifestations are relevant in India, including chikungunya, brucellosis, leptospirosis, dengue and melioidosis. To address the many problems with rheumatology care in India, curricular reforms, capacity building, patient education and political support are sorely needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ministry of Health and Family Welfare, Government of India. Census 2001 and 2011—Key indicators [online], (2014).
World Health Organization. Global Health Observatory Data Repository. Life expectancy data by country [online], (2012).
WHO–Ministry of Health and Family Welfare, Government of India. National action plan and monitoring framework for prevention and control of noncommunicable diseases (NCDs) in India. WHO–Government of India 2012–2013 Biennial Workplan [online], (2014).
Chopra, A. COPCORD—An unrecognized fountainhead of community rheumatology in developing countries. J. Rheumatol. 31, 2320–2323 (2004).
Chopra, A., Patil, J., Billempelly, V., Relwani, J. & Tandle, H. S. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD study. J. Assoc. Physicians India 49, 240–246 (2001).
Joshi, V. L. & Chopra, A. Is there an urban-rural divide? Population surveys of rheumatic musculoskeletal disorders in the Pune region of India using the COPCORD Bhigwan model. J. Rheumatol 36, 614–622 (2009).
Malaviya, A. N., Kapoor, S. K., Singh, R. R., Kumar, A. & Pande, I. Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol. Int. 13, 131–134 (1993).
Central Intelligence Agency. The World Factbook. https://www.cia.gov/library/publications/the-world-factbook/fields/2010.html (2014).
Lagu-Joshi, V., Chanchani, E., Saluja, M., Anuradha, V. & Chopra, A. Prevalence of rheumatic musculoskeletal disorders (RMSK) in a West Indian urban population: a bone and joint decade (BJD) India 'Burden of Disease Project'. American College of Rheumatology [online] (2007).
Chopra, A. & Abdel-Nasser. A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract. Res. Clin. Rheumatol. 22, 583–604 (2008).
Malaviya, A. N., Singh. R. R., Singh, Y. N., Kapoor, S. K. & Kumar, A. Prevalence of systemic lupus erythematosus in India. Lupus 2, 115–118 (1993).
Malaviya, A. N. et al. Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Ind. J. Rheumatol. 5, 16–34 (2010).
Dey, A. B. & Handa, R. Action Plan Osteoporosis. (Osteoporosis Society of India, New Delhi, 2003).
Handa, R., Kalla, A. A. & Maalouf, G. Osteoporosis in developing countries. Best Pract. Res. Clin. Rheumatol. 22, 693–708 (2008).
Malaviya, A. N. et al. Clinical and immunogenetic studies in rheumatoid arthritis from northern India. Rheumatol. Int. 3, 105–108 (1983).
Aggarwal, R. & Malaviya, A. N. Clinical characteristics of patients with ankylosing spondylitis in India. Clin. Rheumatol. 28, 1199–1205 (2009).
Sobti, P. & Bhasin, R. C. Gout in India. (A study of clinical features). J. Assoc. Physicians India 16, 961–965 (1968).
Malaviya, A. N., Chandrasekaran, A. N., Kumar, A. & Shamar, P. N. Systemic lupus erythematosus in India. Lupus 6, 690–700 (1997).
Aggarwal, R. & Malaviya, A. N. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin. Rheumatol. 28, 327–331 (2009).
Handa, R., Wali, J. P., Biswas, A., Aggarwal, P. & Wig, N. Wegener's granulomatosis- A clinicopathologic study. J. Assoc. Physicians India 45, 536–539 (1997).
Handa, R., Farooqi, A. Z., Haq, S. A. & Wali, J. P. Wegener's granulomatosis in the Indian Subcontinent. APLAR J. Rheumatol. 2, 210–215 (1999).
Hadda, V. et al. Disease activity and lipids in rheumatoid arthritis: a prospective study. Ind. J. Rheumatol. 2, 137–140 (2007).
Mahajan, V. et al. Assessment of atherosclerosis by carotid intimomedial thickness in patients with rheumatoid arthritis. J. Assoc. Physicians India 56, 587–590 (2008).
Grover, S. et al. Subclinical atherosclerosis in rheumatoid arthritis in India. J. Rheumatol. 33, 244–247 (2006).
Bhatt, S. P. et al. Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand. J. Rheumatol. 35, 128–132 (2006).
Ghosh, P. et al. Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus. Clin. Rheumatol. 28, 1259–1265 (2009).
Shankar, S. et al. Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol. Int. 29, 377–381 (2009).
Gokhale, Y. A., Bichile, L. S., Gogate, A., Tillu, A. V. & Zamre . Brucella spondylitis: an important treatable cause of low backache. J. Assoc. Physicians India 47, 384–388 (1999).
Kochar, D. K. et al. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J. Assoc. Physicians India 55, 271–275 (2007).
Chopra, A., Anuradha, V., Ghorpade, R. & Saluja, M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol. Infect. 140, 842–850 (2012).
Taraphdar, D., Sarkar, A., Mukhopadhyay, B. B., Chakrabarti, S. & Chatterjee, S. Rapid spread of chikungunya virus following its resurgence during 2006 in West Bengal, India. Trans. R. Soc. Trop. Med. Hyg. 106, 160–166 (2012).
Mathew, A. J. et al. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int. J. Clin. Pract. 65, 1306–1312 (2011).
Chopra, A., Saluja, M. & Venugopalan, A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 66, 319–326 (2014).
Sethi S. et al. Increasing trends of leptospirosis in Northern India: a clinico-epidemiological study. PLoS Negl. Trop. Dis. 4, e579 (2010).
Adebajo, A. O. Dengue arthritis. Br. J. Rheumatol. 35, 909–910 (1996).
Talib, S., Bhattu, S., Bhattu, R., Deshpande, S. & Dahiphale, D. Dengue fever triggering systemic lupus erythematosus and lupus nephritis: a case report. Int. Med. Case Rep. J. 6, 71–75 (2013).
Rajadhyaksha, A. & Mehra, S. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report. Lupus 21, 999–1002 (2012).
Handa, R., Wali, J. P., Singh, S. & Aggarwal, P. A prospective study of Lyme arthritis in north India. Ind. J. Med. Res. 110, 107–109 (1999).
Shyam, C. & Malaviya, A. N. Infection-related morbidity in systemic lupus erythematosus: a clinico-epidemiological study from northern India. Rheumatol. Int. 16, 1–3 (1996).
Dhir, V., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Long-term outcome of lupus nephritis in Asian Indians. Arthritis Care Res. (Hoboken) 64, 713–720 (2012).
Bedi, G. S., Gupta, N., Handa, R., Pal, H. & Pandey, R. M. Quality of life in Indian patients with rheumatoid arthritis. Qual. Life Res. 14, 1953–1958 (2005).
Khanna, S., Pal, H., Pandey, R. M. & Handa, R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford) 43, 1536–1540 (2004).
Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V. & Misra, R. Impact of rheumatoid arthritis on quality of life. Mod. Rheumatol. 17, 290–295 (2007).
Kumar, A. Indian Guidelines on the management of SLE. J. Indian Rheumatol. Assoc. 10, 80–96 (2002).
Misra, R. et al. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J. Rheumatol. 3 (Suppl.), S1–S16 (2008).
Venkataraman, K. et al. Indian Rheumatology Association guidelines for management of glucocorticoid-induced osteoporosis. Endorsed by: Endocrine Society of India and Indian Society for Bone & Mineral Research. Indian J. Rheumatol. 6, 68–75 (2011).
Agarwal, S., Zaman, T. & Handa, R. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Singapore Med. J. 50, 686–692 (2009).
Kumar, A. Experience with anti-tumor necrosis factor-α therapy in India. APLAR J. Rheumatol. 9, 136–141 (2006).
Chaturvedi, V. P. & Singal, V. K. (2004). No case of tuberculosis with low dose infliximab without loading dose in ankylosing spondylitis—retrospective analysis of 108 cases. Presented at the 11th Asia Pacific League of Associations for Rheumatology (APLAR) Congress 2004.
Handa, R. et al. Guidelines for tuberculosis prophylaxis during anti-tumour necrosis factor-α treatment: Indian Rheumatology Association. APLAR J. Rheumatol. 9, 181–183 (2006).
Indian Rheumatology Association. Indian Rheumatology Association Biologics Registry [online] (2010).
Aggarwal, A. & Sawhney, S. From the Editor's desk. Ind. J. Rheumatol. 7 (Suppl.), iv (2012).
Aggarwal, A., Agarwal, V., Danda, D. & Misra, R. Outcome in juvenile rheumatoid arthritis in India. Indian Pediatr. 41, 180–184 (2004).
Sawhney, S. Spectrum of juvenile idiopathic arthritis in a tertiary care centre in northern India. Ind. J. Rheumatol. 14, 3–6 (2006).
Singh, S. et al. Clinico-immunological profile of juvenile rheumatoid arthritis at Chandigarh. Indian Pediatr. 36, 449–454 (1999).
Chandrasekaran, A. N., Rajendran, C. P. & Madhavan, R. Juvenile rheumatoid arthritis—Madras experience. Indian J. Pediatr. 63, 501–510 (1996).
Aggarwal, A. & Misra, R. N. Juvenile rheumatoid arthritis in India—rarity of antinuclear antibody and uveitis. Indian J. Pediatr. 63, 301–304 (1996).
Sawhney, S. & Manners, P. The place of pediatric rheumatology in India. Ind. J. Pediatr. 77, 993–996 (2010).
Kumar, A. et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol. Int. 12, 107–109 (1992).
Murali, R. et al. Systemic lupus erythematosus in Indian patients: Prognosis, survival and life expectancy. Natl Med. J. India 10, 159–164 (1997).
Sharma, A. et al. Causes of mortality among in patients with systemic lupus erythematosus in a tertiary care hospital in North India over a 10-year period. Lupus 22, 216–222 (2013).
Gupta, A., Agarwal, A. & Handa, R. Pregnancy in Indian patients with systemic lupus erythematosus. Lupus 14, 926–927 (2005).
Aggarwal, A., Chandran, S. & Misra, R. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre. Natl Med. J. India 19, 187–191 (2006).
Zaman, T., Agarwal, S. & Handa, R. Complementary and alternative medicine use in rheumatoid arthritis- An audit of patients visiting a tertiary care centre. Natl Med. J. India 20, 236–239 (2007).
Rao, P. & Prasanna, N. M. Immunological studies on rheumatoid arthritis treated with homeopathic drugs: results of the pilot study. Ind. J. Res. Homoeopathy 2, 42–49 (2008).
Chopra, A. Ayurvedic medicine and arthritis. Rheum. Dis. Clin. North Am. 26, 133–144 (2000).
Chopra, A. & Doiphode, V. V. Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med. Clin. North Am. 86, 75–89 (2002).
Basnyat, S. & Kolasinski, S. L. Ayurvedic medicine for rheumatoid arthritis. Curr. Rheumatol. Rep. 16, 435 (2014).
Chopra, A. et al Randomized controlled exploratory evaluation of standardized ayurvedic formulations in symptomatic osteoarthritis knees: a government of India NMITLI project. Evid. Based Complement. Alternat. Med. 2011, 724291 (2011).
Chopra, A. et al. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquinesulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clin. Rheumatol. 31, 259–269 (2012).
Chopra, A. et al. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 52, 1408–1417 (2013).
Handa R. Rheumatology in postgraduate curriculum. Indian J. Rheumatol. 9, 127–130 (2014).
Acknowledgements
The opinions expressed in this article are mine, and do not necessarily reflect the views of the Indian Rheumatology Association, the Asia–Pacific League of Associations for Rheumatology (APLAR), the International League of Associations for Rheumatology (ILAR) or the Indian government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Handa, R. Rheumatology in India—quo vadis?. Nat Rev Rheumatol 11, 183–188 (2015). https://doi.org/10.1038/nrrheum.2014.182
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.182
This article is cited by
-
Moving towards online rheumatology education in the era of COVID-19
Clinical Rheumatology (2020)
-
Advances in rheumatology practice in Brazil
Rheumatology International (2019)
-
Rheumatology science and practice in India
Rheumatology International (2018)